Provided are compounds of Formula I: and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of virus infections, particularly hepatitis C infections.
申请公布号
SG11201408064P(A)
申请公布日期
2015.01.29
申请号
SG11201408064P
申请日期
2013.06.07
申请人
GILEAD SCIENCES, INC.;SELCIA LIMITED
发明人
STEADMAN, VICTORIA ALEXANDRA;POULLENNEC, KARINE G.;LAZARIDES, LINOS;ACIRO, CAROLINE;DEAN, DAVID KENNETH;KEATS, ANDREW JOHN;SIEGEL, DUSTIN SCOTT;SCHRIER, ADAM JAMES;MACKMAN, RICHARD;JANSA, PETR